Sales up by 48% at EUR958 Million - EBITDA Margin Reaches High Level
Another Acquisition in the Target Segment of Pharmaceutical Plastics in
South America: Brazilian Market Leader for Pharma Plastic Taken Over
DUSSELDORF, Germany, Feb. 4 /CNW/ - According to provisional figures,
Gerresheimer AG has just completed another record year. In 2007 the company
achieved sales of EUR957.7m, up by 48.1%; the adjusted Group EBITDA margin
reached 19%. "This gratifying development completely and fully confirms our
strategy," says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG:
"With the help of acquisitions we have successfully expanded our global
presence and set the course for further growth."
Rapid expansion of operations in the South American pharma and life
Shortly after taking over EDP S.A. with production in Spain and South
America, this international company based in Dusseldorf, Germany, now
announces the acquisition of ALLPLAS Embalagens Ltda. (Sao Paulo), which is
the market leader for pharmaceutical plastic packaging in Brazil. This marks
the successful completion of another important step in the global expansion of
the Gerresheimer Group.
For Gerresheimer's Plastic Systems Division, finalisation of the latest
contract puts the cap on a dramatic move into South America. It was only at
the end of December last year that Gerresheimer, as reported, acquired EDP,
the Spanish market leader for pharmaceutical PET bottles, thereby also
establishing a foothold in South America for the first time. With Allplas,
which operates two production plants in Sao Paulo, Gerresheimer now already
has three strategically important bases in the region.
The Brazilian company is a well-established supplier to the
pharmaceutical industry, with innovative products and a reputation for high
quality. Allplas manufactures high-calibre vials and application and closure
systems for liquid formulations and solid dosages (for example eye drops and
tablets), which ideally complement - and can be combined with - Gerresheimer's
product range. The Group's existing product portfolio in the field of plastic
packaging, which has so far been marketed primarily in Europe, will as a
result increasingly find its way into the South American pharmaceutical
Allplas currently achieves annual sales equivalent to around EUR16m. The
EBITDA margin is 16%, which will be continuously improved in the years ahead.
Integration in the Gerresheimer Group is to be completed by mid-2008. Like
EDP, Allplas will become part of Gerresheimer Plastic Packaging, which
specialises in pharmaceutical primary packaging and application systems under
leading trade-marks such as Duma(R), Dudek(TM) and EDP(TM). Together with the
two acquisitions, Gerresheimer's plastic operations achieve a total annual
sales volume of around EUR350m, of which around EUR100m is attributable to the
plastic packaging segment.
Including the two acquisitions, Gerresheimer employs more than 10,800
people in forty locations in Europe, America and Asia. In the financial year
2007, worldwide sales totalled EUR957.7m. The product portfolio ranges from
pharmaceutical vials made of glass and plastic to complex drug-delivery
systems for the pharma and life-science industry. These include sterile
syringes, inhalers and other system solutions for secure dosage and
application of medications. The Group enjoys a leading position in a market
which is characterised by high technical and regulatory barriers.
Gerresheimer's products are subject to extremely rigorous quality requirements
stipulated by the international pharmaceutical supervision authorities.
Annual Press Conference February 26, 2008
Annual General Meeting April 17, 2008
For further information:
For further information: Burkhard Lingenberg, Director Corporate PR &
Marketing, Telephone: +49-211-6181-250, Telefax: +49-211-6181-241, e-mail: